表紙:いびき防止治療市場- 成長、将来展望、競合分析、2023年~2031年
市場調査レポート
商品コード
1293827

いびき防止治療市場- 成長、将来展望、競合分析、2023年~2031年

Anti-Snoring Treatment Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: | 発行: Acute Market Reports | ページ情報: 英文 119 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
いびき防止治療市場- 成長、将来展望、競合分析、2023年~2031年
出版日: 2023年06月02日
発行: Acute Market Reports
ページ情報: 英文 119 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

いびき防止治療市場は、いびきの有病率の増加と健康への影響に対する意識の高まりにより、2023年から2031年の予測期間中に10.8%のCAGRで成長すると予測されています。いびきは、睡眠中に空気の流れが妨げられることによって引き起こされる一般的な症状であり、その結果、大きな音や不快な騒音が発生します。いびきは、いびきをかく人とそのパートナーの睡眠の質に影響を与えるだけでなく、日中の疲労、心血管系の問題、認知機能の低下など、さまざまな健康問題につながる可能性があります。いびき防止治療の世界市場は、予測期間中、顕著なCAGRで、市場収益の著しい増加が見込まれています。市場収益の増加は、いくつかの要因に起因しています。まず、いびきが健康に及ぼす影響に関する意識の高まりにより、効果的な治療オプションへの需要が高まっています。人々は、いびきの問題を軽減するための解決策を積極的に求めるようになり、いびき防止装置や治療法の採用につながりました。次に、技術や製品の革新の進歩により、幅広い種類のいびき防止治療オプションが開発されました。下顎前突装置、舌安定装置、鼻腔装置、口腔器具、外科的介入などです。いびきの原因や好みに応じて多様な治療法が用意されていることが、市場の成長に寄与しています。最後に、医療費の増加や医療従事者による睡眠障害への注目の高まりが、いびき防止治療sの需要をさらに促進しています。

意識と健康への懸念の高まり

いびきが健康に与える影響に関する意識の高まりは、いびき防止治療市場の主要な促進要因となっています。いびきが健康に及ぼす悪影響について人々が知識を深めるにつれ、効果的な治療法に対する需要が高まっています。例えば、いびきは心血管疾患、高血圧、脳卒中のリスク上昇と関連しています。Chest誌に掲載された研究では、習慣的ないびきは高血圧発症の独立した危険因子であることが判明しています。このような認識から、睡眠の質を高め、健康全般を改善するためにいびき防止治療を求める個人の意欲が高まっています。

技術の進歩と製品の革新

いびき防止治療の分野における技術の進歩は、革新的な製品や治療法の開発につながっています。この推進力には、下顎前突装置(MAD)や舌安定装置(TSD)といった装置のイントロダクションが含まれます。MADは下顎の位置を変えることで気道を開き、TSDは舌を安定させることで睡眠中の舌の崩れを防ぐことを目的としています。これらの装置は、その有効性と使いやすさから人気を博しています。例えば、Journal of Clinical Sleep Medicine誌に掲載された研究では、特定のMADの有効性を評価し、いびきを有意に減少させ、睡眠の質を改善することが判明しました。

非侵襲的な治療オプションへの需要の高まり

いびき防止治療市場のもう一つの促進要因は、非侵襲的な治療オプションに対する需要の高まりです。多くの人が、いびきの問題を解決するために、非外科的・非薬物的アプローチを好んでいます。この需要は、利便性、費用対効果、副作用の少なさといった要因によってもたらされます。その結果、鼻腔拡張器や鼻腔ストリップなどのデバイスが市場で人気を博しています。これらの製品は、鼻腔を開き、空気の流れを改善し、いびきを軽減することで効果を発揮します。Sleep and Breathing誌に掲載された研究では、いびきの軽減と睡眠の質の向上に鼻腔拡張器が有効であることが実証されています。

治療のコンプライアンスと有効性の欠如

いびき防止治療市場における大きな抑制要因の1つは、治療のコンプライアンスと効果の問題です。機器や治療法など、さまざまな治療法がありますが、これらの治療法の成功率や長期的な効果には個人差があります。特に、睡眠中に装着する必要のある口腔内装置や鼻腔内装置などでは、治療計画の遵守が困難な場合があります。多くの人がこれらの装置を不快に感じたり、不便に感じたりすることで、アドヒアランスが低下し、治療効果の低下につながる可能性があります。Chest誌に掲載された研究では、いびき治療のために口腔内装置を使用している患者のコンプライアンスを調査したところ、時間の経過とともにアドヒアランスが低下し、1年後に装置を定期的に使用している患者はわずかな割合であることがわかりました。さらに、特定のいびき防止治療の有効性は、いびきの根本的な原因によって異なる場合があります。例えば、いびきの主な原因が鼻づまりやアレルギーである場合、鼻用デバイスや拡張器は、舌の位置や顎の位置など他の要因をターゲットにした治療と比較して、効果が低い場合があります。このような治療のコンプライアンスや効果に関する課題は、いびき防止治療の全体的な成功や効果を制限し、市場の成長や採用の抑制要因となり得ます。

デバイス別では鼻腔用デバイスが市場の売上を独占

いびき防止治療市場は、口腔内装置、鼻腔内装置、体位変換装置、あごひも、舌安定装置、呼気陽圧(EPAP)療法装置など、さまざまなデバイスカテゴリーに分類されます。これらのセグメントの中で、2023年から2031年の予測期間中に最もCAGRが高くなると予想されるのは、口腔アプライアンスです。下顎前進装置(MAD)などの口腔器具は、下顎の位置を変えて気道を開き、睡眠中の気流を改善することでいびきを治療するために一般的に使用されています。これらの器具は便利で簡単に使用できるため、いびきをかく人の間で人気が高まっています。さらに、Journal of Clinical Sleep Medicine誌に掲載された研究により、口腔内装置はいびきの軽減と睡眠の質の向上において有望な結果を示しています。最も高い収益を上げた点では、2022年に鼻腔用デバイス分野が市場を独占しています。鼻腔拡張器や鼻腔ストリップを含む鼻腔デバイスは、鼻の気流を改善し、鼻づまりや虚脱によって引き起こされるいびきを軽減することで機能します。これらのデバイスは非侵襲的であり、すぐに緩和されるため、非外科的な治療オプションを求める人々に好まれる選択肢となっています。さらに、鼻腔拡張器は、Sleep and Breathing誌に掲載された研究により、いびきの強さを効果的に低減し、睡眠の質を改善することが判明しています。

UPPPが外科的処置で市場を席巻

いびき防止治療市場には、いびきや睡眠関連呼吸障害への対処を目的としたさまざまな外科的処置が含まれています。これらのセグメントの中で、2023年から2031年の予測期間中に最も高いCAGRを記録すると予想されるのが外科手術セグメントです。外科的介入は、気道閉塞の原因となる解剖学的問題に対処することで、いびきの長期的な解決策を提供します。CAGRが最も高い外科的処置の1つは、レーザー支援外耳道形成術(LAUP)です。LAUPは、レーザーで喉の余分な組織(口蓋垂や軟口蓋など)を切除したり、形を変えたりして、気道を広げ、いびきを軽減させるものです。この手術は、Journal of Laryngology &Otology誌やChest誌に掲載された研究により、いびきの軽減や睡眠の質の向上に有望な結果を示しています。最も高い収益を上げたという点では、2022年の市場を独占したのは、葡萄口蓋咽頭形成術(UPPP)でした。UPPPは、気道を広げ、いびきを軽減するために、喉の余分な組織(口蓋垂、扁桃腺、軟口蓋の一部を含む)を外科的に除去または再配置することを含みます。いびきや睡眠時無呼吸症候群に対する標準的な手術方法と考えられています。いびきを軽減するUPPPの効果は、American Journal of Respiratory and Critical Care Medicineに掲載されたシステマティックレビューを含む複数の研究で証明されています。

目次

第1章 序文

  • レポート内容
    • 報告書の目的
    • 対象読者
    • 主な提供商品
  • 市場セグメンテーション
  • 調査手法
    • フェーズⅠ-二次調査
    • フェーズⅡ-一次調査
    • フェーズⅢ-有識者別レビュー
    • 前提条件
    • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 いびき防止治療市場:競合分析

  • 主要ベンダーの市場での位置付け
  • ベンダーが採用する戦略
  • 主要な産業戦略
  • ティア分析:2022 vs 2031

第4章 いびき防止治療市場:マクロ分析と市場力学

  • イントロダクション
  • 世界のいびき防止治療市場金額 2021-2031
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 いびき防止治療市場:デバイス別 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • 口腔器具
      • 下顎前進装置(MAD)
      • 舌保持装置
    • 経鼻装置
      • 外部鼻拡張器
      • その他の経鼻器具
    • 位置制御装置
    • あご紐
    • 舌を安定させる装置
    • 呼気気道陽圧(EPAP)治療装置

第6章 いびき防止治療市場:タイプ別 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • レーザー支援別口蓋垂口蓋形成術
    • 高周波アブレーション
    • 柱となる手順
    • 口蓋垂口蓋咽頭形成術(UPPP)
    • 注射いびき形成術
    • 口蓋の硬化
    • その他の外科的処置

第7章 いびき防止治療市場:流通チャネル別 2021-2031

  • 市場概要
  • 成長・収益分析:2022 vs 2031
  • 市場セグメンテーション
    • 病院
    • クリニック
    • 小売薬局
    • eコマース
    • その他

第8章 北米のいびき防止治療市場 2021-2031

  • 市場概要
  • いびき防止治療市場:デバイス別 2021-2031
  • いびき防止治療市場:タイプ別 2021-2031
  • いびき防止治療市場:流通チャネル別 2021-2031
  • いびき防止治療市場:地域別 2021-2031
    • 北米
      • 米国
      • カナダ
      • その他北米地域

第9章 英国と欧州連合のいびき防止治療市場 2021-2031

  • 市場概要
  • いびき防止治療市場:デバイス別 2021-2031
  • いびき防止治療市場:タイプ別 2021-2031
  • いびき防止治療市場:流通チャネル別 2021-2031
  • いびき防止治療市場:地域別 2021-2031
    • 英国と欧州連合
      • 英国
      • ドイツ
      • スペイン
      • イタリア
      • フランス
      • その他欧州地域

第10章 アジア太平洋のいびき防止治療市場 2021-2031

  • 市場概要
  • いびき防止治療市場:デバイス別 2021-2031
  • いびき防止治療市場:タイプ別 2021-2031
  • いびき防止治療市場:流通チャネル別 2021-2031
  • いびき防止治療市場:地域別 2021-2031
    • アジア太平洋
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 ラテンアメリカのいびき防止治療市場 2021-2031

  • 市場概要
  • いびき防止治療市場:デバイス別 2021-2031
  • いびき防止治療市場:タイプ別 2021-2031
  • いびき防止治療市場:流通チャネル別 2021-2031
  • いびき防止治療市場:地域別 2021-2031
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • その他ラテンアメリカ地域

第12章 中東・アフリカのいびき防止治療市場 2021-2031

  • 市場概要
  • いびき防止治療市場:デバイス別 2021-2031
  • いびき防止治療市場:タイプ別 2021-2031
  • いびき防止治療市場:流通チャネル別 2021-2031
  • いびき防止治療市場:地域別 2021-2031
    • 中東・アフリカ
      • GCC
      • アフリカ
      • その他中東・アフリカ地域

第13章 企業プロファイル

  • Apnea Science
  • SomnoMed
  • Koninklijke Philips
  • Airway Management Inc
  • Tomed GmBH
  • Meditas
  • Fisher & Paykel Healthcare
  • ResMed
  • The Pure Sleep Co(Sleep Science Partners Inc)
  • その他の注目企業
図表

List of Tables

  • TABLE 1 Global Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 2 Global Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 3 Global Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 4 Global Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 5 Global Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 6 Global Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 7 North America Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 8 North America Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 9 North America Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 10 North America Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 11 North America Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 12 North America Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 13 U.S. Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 14 U.S. Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 15 U.S. Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 16 U.S. Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 17 U.S. Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 18 U.S. Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 19 Canada Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 20 Canada Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 21 Canada Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 22 Canada Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 23 Canada Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 24 Canada Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 26 Rest of North America Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 27 Rest of North America Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 28 Rest of North America Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 29 Rest of North America Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 30 Rest of North America Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 31 UK and European Union Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 32 UK and European Union Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 33 UK and European Union Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 34 UK and European Union Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 35 UK and European Union Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 36 UK and European Union Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 37 UK Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 38 UK Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 39 UK Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 40 UK Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 41 UK Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 42 UK Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 43 Germany Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 44 Germany Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 45 Germany Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 46 Germany Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 47 Germany Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 48 Germany Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 49 Spain Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 50 Spain Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 51 Spain Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 52 Spain Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 53 Spain Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 54 Spain Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 55 Italy Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 56 Italy Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 57 Italy Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 58 Italy Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 59 Italy Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 60 Italy Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 61 France Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 62 France Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 63 France Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 64 France Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 65 France Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 66 France Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 67 Rest of Europe Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 68 Rest of Europe Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 69 Rest of Europe Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 70 Rest of Europe Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 71 Rest of Europe Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 72 Rest of Europe Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 73 Asia Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 74 Asia Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 75 Asia Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 76 Asia Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 77 Asia Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 78 Asia Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 79 China Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 80 China Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 81 China Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 82 China Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 83 China Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 84 China Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 85 Japan Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 86 Japan Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 87 Japan Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 88 Japan Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 89 Japan Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 90 Japan Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 91 India Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 92 India Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 93 India Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 94 India Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 95 India Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 96 India Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 97 Australia Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 98 Australia Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 99 Australia Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 100 Australia Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 101 Australia Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 102 Australia Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 103 South Korea Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 104 South Korea Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 105 South Korea Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 106 South Korea Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 107 South Korea Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 108 South Korea Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 109 Latin America Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 110 Latin America Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 111 Latin America Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 112 Latin America Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 113 Latin America Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 114 Latin America Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 115 Brazil Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 116 Brazil Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 117 Brazil Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 118 Brazil Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 119 Brazil Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 120 Brazil Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 121 Mexico Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 122 Mexico Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 123 Mexico Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 124 Mexico Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 125 Mexico Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 126 Mexico Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 127 Rest of Latin America Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 128 Rest of Latin America Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 129 Rest of Latin America Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 130 Rest of Latin America Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 131 Rest of Latin America Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 132 Rest of Latin America Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 133 Middle East and Africa Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 134 Middle East and Africa Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 135 Middle East and Africa Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 136 Middle East and Africa Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 137 Middle East and Africa Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 138 Middle East and Africa Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 139 GCC Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 140 GCC Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 141 GCC Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 142 GCC Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 143 GCC Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 144 GCC Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 145 Africa Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 146 Africa Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 147 Africa Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 148 Africa Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 149 Africa Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 150 Africa Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)
  • TABLE 151 Rest of Middle East and Africa Anti-Snoring Treatment Market By Device, 2021-2031, USD (Million)
  • TABLE 152 Rest of Middle East and Africa Anti-Snoring Treatment Market By Oral Appliances, 2021-2031, USD (Million)
  • TABLE 153 Rest of Middle East and Africa Anti-Snoring Treatment Market By Mandibular Advancement Devices (MADs), 2021-2031, USD (Million)
  • TABLE 154 Rest of Middle East and Africa Anti-Snoring Treatment Market By Nasal Devices, 2021-2031, USD (Million)
  • TABLE 155 Rest of Middle East and Africa Anti-Snoring Treatment Market By Type, 2021-2031, USD (Million)
  • TABLE 156 Rest of Middle East and Africa Anti-Snoring Treatment Market By Distribution Channel, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Anti-Snoring Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Anti-Snoring Treatment Market: Quality Assurance
  • FIG. 5 Global Anti-Snoring Treatment Market, By Device, 2022
  • FIG. 6 Global Anti-Snoring Treatment Market, By Type, 2022
  • FIG. 7 Global Anti-Snoring Treatment Market, By Distribution Channel, 2022
  • FIG. 8 Global Anti-Snoring Treatment Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Anti-Snoring Treatment Market, 2022
  • FIG. 10 Market Positioning of Key Anti-Snoring Treatment Market Players, 2022
  • FIG. 11 Global Anti-Snoring Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 12 Global Anti-Snoring Treatment Market, By Device, 2022 Vs 2031, %
  • FIG. 13 Global Anti-Snoring Treatment Market, By Type, 2022 Vs 2031, %
  • FIG. 14 Global Anti-Snoring Treatment Market, By Distribution Channel, 2022 Vs 2031, %
  • FIG. 15 U.S. Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 22 France Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 24 China Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 26 India Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Anti-Snoring Treatment Market (US$ Million), 2021 - 2031
目次
Product Code: 139606-06-23

The anti-snoring treatment market is expected to grow at a CAGR of 10.8% during the forecast period of 2023 to 2031, driven by the increasing prevalence of snoring and the growing awareness of its health implications. Snoring is a common condition caused by the obstruction of airflow during sleep, resulting in loud and disruptive noises. It not only affects the quality of sleep for both the snorer and their bed partner but can also lead to various health issues such as daytime fatigue, cardiovascular problems, and decreased cognitive function. The global anti-snoring treatment market is expected to witness a significant increase in market revenue, with a notable compound annual growth rate (CAGR) over the forecast period. The rise in market revenue can be attributed to several factors. Firstly, the growing awareness about the health consequences of snoring has led to an increased demand for effective treatment options. People are more proactive in seeking solutions to alleviate their snoring problems, leading to the adoption of anti-snoring devices and therapies. Secondly, advancements in technology and product innovation have resulted in the development of a wide range of anti-snoring treatment options. These include mandibular advancement devices, tongue stabilizing devices, nasal devices, oral appliances, and surgical interventions. The availability of a diverse range of treatments catering to different snoring causes and preferences has contributed to market growth. Lastly, the rise in healthcare expenditure and the increasing focus on sleep disorders by healthcare providers have further propelled the demand for anti-snoring treatments.

Growing Awareness and Health Concerns

The increasing awareness about the health implications of snoring is a key driver for the anti-snoring treatment market. As people become more knowledgeable about the adverse effects of snoring on their health, there is a growing demand for effective treatment options. For instance, snoring has been associated with an increased risk of cardiovascular diseases, hypertension, and stroke. A study published in the journal Chest found that habitual snoring is an independent risk factor for the development of hypertension. This awareness has motivated individuals to seek anti-snoring treatments to improve their sleep quality and overall health.

Technological Advancements and Product Innovation

Technological advancements in the field of anti-snoring treatment have led to the development of innovative products and therapies. This driver includes the introduction of devices such as mandibular advancement devices (MADs) and tongue stabilizing devices (TSDs). MADs work by repositioning the lower jaw to open the airway, while TSDs aim to stabilize the tongue to prevent its collapse during sleep. These devices have gained popularity due to their effectiveness and ease of use. For example, a study published in the Journal of Clinical Sleep Medicine evaluated the efficacy of a specific MAD and found that it significantly reduced snoring and improved sleep quality.

Increasing Demand for Non-Invasive Treatment Options

Another driver of the anti-snoring treatment market is the rising demand for non-invasive treatment options. Many individuals prefer non-surgical and non-pharmacological approaches to address their snoring issues. This demand is driven by factors such as convenience, cost-effectiveness, and minimal side effects. As a result, devices like nasal dilators and nasal strips have gained traction in the market. These products work by opening the nasal passages, improving airflow, and reducing snoring. A study published in the journal Sleep and Breathing demonstrated the efficacy of nasal dilators in reducing snoring and improving sleep quality.

Lack of Treatment Compliance and Effectiveness

One major restraint in the anti-snoring treatment market is the issue of treatment compliance and effectiveness. While there are various treatment options available, including devices and therapies, the success rate and long-term effectiveness of these treatments can vary among individuals. Compliance with treatment regimens can be challenging, especially for devices such as oral appliances and nasal devices that need to be worn during sleep. Many individuals may find these devices uncomfortable or inconvenient, leading to low adherence and reduced treatment effectiveness. A study published in the journal Chest examined the compliance of patients using an oral appliance for snoring treatment and found that adherence decreased over time, with only a small percentage of patients using the device regularly after one year. Additionally, the effectiveness of certain anti-snoring treatments may vary based on the underlying causes of snoring. For example, if snoring is primarily caused by nasal congestion or allergies, nasal devices or dilators may be less effective compared to treatments targeting other factors such as tongue position or jaw alignment. These challenges in treatment compliance and effectiveness can limit the overall success and impact of anti-snoring treatments, posing a restraint to the market's growth and adoption.

The Nasal Devices Dominated the Revenues for the Market by Devices

The anti-snoring treatment market is segmented into various device categories, including oral appliances, nasal devices, position control devices, chin straps, tongue-stabilizing devices, and expiratory positive airway pressure (EPAP) therapy devices. Among these segments, oral appliances are expected to have the highest CAGR during the forecast period of 2023 to 2031. Oral appliances, such as mandibular advancement devices (MADs), are commonly used to treat snoring by repositioning the lower jaw and opening the airway to improve airflow during sleep. These devices offer convenience and ease of use, contributing to their growing popularity among snorers. Additionally, oral appliances have shown promising results in reducing snoring and improving sleep quality, as indicated by a study published in the Journal of Clinical Sleep Medicine. In terms of the highest revenue, the nasal devices segment dominated the market in 2022. Nasal devices, including nasal dilators and nasal strips, work by improving nasal airflow and reducing snoring caused by nasal congestion or collapse. These devices are non-invasive and provide immediate relief, making them a preferred choice for individuals seeking non-surgical treatment options. Furthermore, nasal dilators have been found to effectively reduce snoring intensity and improve sleep quality, as demonstrated in a study published in the journal Sleep and Breathing.

UPPP Dominates the Market by Surgical Procedures

The anti-snoring treatment market includes various surgical procedures aimed at addressing snoring and sleep-related breathing disorders. Among these segments, the surgery segment is expected to witness the highest CAGR during the forecast period of 2023 to 2031. Surgical interventions offer long-term solutions for snoring by addressing anatomical issues that contribute to airway obstruction. One of the surgical procedures with the highest CAGR is laser-assisted uvulopalatoplasty (LAUP). LAUP involves the use of a laser to remove or reshape excess tissues in the throat, including the uvula and soft palate, to increase the size of the airway and reduce snoring. The procedure has shown promising results in reducing snoring and improving sleep quality, as indicated by studies published in the Journal of Laryngology & Otology and the journal Chest. In terms of the highest revenue, uvulopalatopharyngoplasty (UPPP) dominated the market in 2022. UPPP involves the surgical removal or repositioning of excess tissues in the throat, including the uvula, tonsils, and parts of the soft palate, to widen the airway and reduce snoring. It is considered a standard surgical procedure for snoring and sleep apnea. The effectiveness of UPPP in reducing snoring has been demonstrated in multiple studies, including a systematic review published in the American Journal of Respiratory and Critical Care Medicine.

Historical & Forecast Period

This study report represents an analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends, and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. A key data point that enables the estimation of Anti-Snoring Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price, and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Anti-Snoring Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approaches for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Device

  • Oral Appliances
  • Mandibular Advancement Devices (MADs)
    • Non-custom MADs
    • Custom-made MADs
    • Tongue-retaining Devices
  • Nasal Devices
    • External Nasal Dilators
    • Other Nasal Devices
  • Position Control Devices
  • Chin Straps
  • Tongue-stabilizing Devices
  • Expiratory Positive Airway Pressure (EPAP) Therapy Devices

Type

  • Laser-assisted Uvulopalatoplasty
  • Radiofrequency Ablation
  • Pillar Procedure
  • Uvulopalatopharyngoplasty (UPPP)
  • Injection Snoreplasty
  • Palatal Stiffening
  • Other Surgical Procedures

Distribution Channel

  • Hospitals
  • Clinics
  • Retail pharmacies
  • E-commerce
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Anti-Snoring Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Anti-Snoring Treatment market?
  • Which is the largest regional market for Anti-Snoring Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Anti-Snoring Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Anti-Snoring Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Anti-Snoring Treatment Market
  • 2.2. Global Anti-Snoring Treatment Market, By Device, 2022 (US$ Million)
  • 2.3. Global Anti-Snoring Treatment Market, By Type, 2022 (US$ Million)
  • 2.4. Global Anti-Snoring Treatment Market, By Distribution Channel, 2022 (US$ Million)
  • 2.5. Global Anti-Snoring Treatment Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Anti-Snoring Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Anti-Snoring Treatment Market Vendors
  • 3.2. Strategies Adopted by Anti-Snoring Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Anti-Snoring Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Anti-Snoring Treatment Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Oral Appliances
      • 5.3.1.1. Mandibular Advancement Devices (MADs)
        • 5.3.1.1.1. Non-custom MADs
        • 5.3.1.1.2. Custom-made MADs
      • 5.3.1.2. Tongue-retaining Devices
    • 5.3.2. Nasal Devices
      • 5.3.2.1. External Nasal Dilators
      • 5.3.2.2. Other Nasal Devices
    • 5.3.3. Position Control Devices
    • 5.3.4. Chin Straps
    • 5.3.5. Tongue-stabilizing Devices
    • 5.3.6. Expiratory Positive Airway Pressure (EPAP) Therapy Devices

6. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Laser-assisted Uvulopalatoplasty
    • 6.3.2. Radiofrequency Ablation
    • 6.3.3. Pillar Procedure
    • 6.3.4. Uvulopalatopharyngoplasty (UPPP)
    • 6.3.5. Injection Snoreplasty
    • 6.3.6. Palatal Stiffening
    • 6.3.7. Other Surgical Procedures

7. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Retail pharmacies
    • 7.3.4. E-commerce
    • 7.3.5. Others

8. North America Anti-Snoring Treatment Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
  • 8.3. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
  • 8.4. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 8.5.Anti-Snoring Treatment Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 8.5.1.1.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.1.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 8.5.1.2.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.2.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 8.5.1.3.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 8.5.1.3.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

9. UK and European Union Anti-Snoring Treatment Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
  • 9.3. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
  • 9.4. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 9.5.Anti-Snoring Treatment Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.1.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.1.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.2.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.2.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.3.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.3.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.4.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.4.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.5.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.5.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 9.5.1.6.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 9.5.1.6.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

10. Asia Pacific Anti-Snoring Treatment Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
  • 10.3. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
  • 10.4. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 10.5.Anti-Snoring Treatment Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.1.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.1.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.2.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.2.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.3.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.3.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.4.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.4.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.5.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.5.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 10.5.1.6.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 10.5.1.6.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

11. Latin America Anti-Snoring Treatment Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
  • 11.3. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
  • 11.4. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 11.5.Anti-Snoring Treatment Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 11.5.1.1.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.1.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 11.5.1.2.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.2.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 11.5.1.3.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 11.5.1.3.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

12. Middle East and Africa Anti-Snoring Treatment Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
  • 12.3. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
  • 12.4. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
  • 12.5.Anti-Snoring Treatment Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 12.5.1.1.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.1.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 12.5.1.2.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.2.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Anti-Snoring Treatment Market: By Device, 2021-2031, USD (Million)
        • 12.5.1.3.1. Anti-Snoring Treatment Market: By Type, 2021-2031, USD (Million)
        • 12.5.1.3.1. Anti-Snoring Treatment Market: By Distribution Channel, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Apnea Science
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. SomnoMed
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Koninklijke Philips
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Airway Management Inc
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Tomed GmBH
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Meditas
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Fisher & Paykel Healthcare
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. ResMed
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. The Pure Sleep Co (Sleep Science Partners, Inc)
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Other Notable Players
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives